Loneliness may not be a direct cause of disease

A study reveals loneliness correlates with 13 illness categories, highlighting its role as a potential proxy marker rather than a direct risk factor.

Atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants | Psychedelic Invest

VLS-01, a proprietary oral transmucosal film (OTF) formulation of DMT, was well-tolerated with a favorable safety profile Pharmacokinetic and pharmacodynamic data confirmed systemic delivery of

October 3, 2023

Hybrid schistosomes from cattle complicate human disease control

Effective control of bovine schistosomiasis will be required to meet disease elimination targets in humans, new research shows.

June 26, 2024

SciSparc signs patent license deal with Polyrizon for pain therapy

SciSparc will earn royalties from the commercialisation of the pain therapy. Credit: Wasan Tita/Shutterstock. Israel-based pharmaceutical company SciSparc has signed an exclusive patent licence agreement

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.